MEK Inhibitor News and Research

RSS
Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Study uncovers potential new treatment approach for lung cancer

Study uncovers potential new treatment approach for lung cancer

New drug combination found to be effective against uveal melanoma in preclinical studies

New drug combination found to be effective against uveal melanoma in preclinical studies

Gene mutation discovery leads to novel treatment for patient with severe lymphatic condition

Gene mutation discovery leads to novel treatment for patient with severe lymphatic condition

Certain cancer drugs induce stem cell plasticity in colorectal cancer

Certain cancer drugs induce stem cell plasticity in colorectal cancer

Study finds promising new treatment for infants with Noonan Syndrome

Study finds promising new treatment for infants with Noonan Syndrome

New clinical genomic testing helps identify mutations that drive childhood melanoma

New clinical genomic testing helps identify mutations that drive childhood melanoma

Study uncovers a protein involved in lung cancer treatment resistance

Study uncovers a protein involved in lung cancer treatment resistance

Researchers discover how MAPK translocation leads to drug resistance in melanoma

Researchers discover how MAPK translocation leads to drug resistance in melanoma

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

New avenue for cancer treatment opens when one drug fails

New avenue for cancer treatment opens when one drug fails

Changing schedules of targeted therapy for melanoma could improve outcomes

Changing schedules of targeted therapy for melanoma could improve outcomes

Study reports longer survival for obese men with metastatic melanoma

Study reports longer survival for obese men with metastatic melanoma

Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows

Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows

Treatment for skin cancer could be more effective if combined with arthritis drug

Treatment for skin cancer could be more effective if combined with arthritis drug

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination therapy shows potential for effective treatment of RAS-mutant cancers

Combination therapy shows potential for effective treatment of RAS-mutant cancers

KRAS ‘imbalances’ that emerge over time may influence cancer treatment response

KRAS ‘imbalances’ that emerge over time may influence cancer treatment response

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression